The information contained on the NEUROGENX websites is for informational purposes only. While we try to maintain current and accurate information, no warranty is made that the information is error-free. Information may change at any time without notice.
NEUROGENX does not assume any responsibility or risk for your use of the company’s web content, websites, or mobile application(s), is not responsible for any changes that may be required by your Internet Service Provider (ISP), and will in no event be liable to you or anyone else for any decision made or action taken by you or anyone else in reliance upon the information provided via the NEUROGENX websites, or mobile application(s).As the recipient of this information, you assume full responsibility for using the information at this web site, and you understand and agree that NEUROGENX is neither responsible nor liable for any claim, loss, or damage resulting from its use.
The mention of specific products, services or providers on these websites does not constitute or imply a recommendation or endorsement by NEUROGENX, unless it is explicitly stated. The views and opinions of authors do not necessarily state or reflect those of NEUROGENX.
On average, patients who receive the NEUROGENX treatment experience an 87% reduction in symptoms, based on an April 2012 published medical study. Individual results may vary depending on the patient’s age, condition, treatment compliance, genetics, diagnosis and other factors. Not all patients are candidates for treatment or are accepted for care.